24Sep
24Sep
Immusoft to Announce Positive Phase 1 Data for First Engineered B Cell Therapy in a Clinical Trial
Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation (""Immusoft""), a cell therapy company dedicated to improving the lives of patients with rare diseases, today announced positive results from the Phase 1 ISP-001 trial evaluating the therapy in a patient with mucopolysaccharidosis type I (MPS I). The clinical trial is supported by an $8 million award from the California Institute for Regenerative Medicine (CIRM), one of the world's largest institutes dedicated to regenerative medicine. ""Although the Phase 1 focus...
21Sep
University of Arizona Professor Recognized for VR Sight-Enhancing Tech
A longtime University of Arizona optics professor has been honored along with other scientists who used federal funding to invent life-changing technology — in Hong Hua’s case, helping the nearly blind to see clearly. Hua, director of the UA’s 3D Visualization and Imaging Systems laboratory, was featured in the Bayh-Dole Coalition’s 2024 “Faces of American Innovation” report for her invention of an optical device that uses virtual- and augmented-reality technology to allow those with significant vision loss to see with...
18Sep
EarthGrid Announces Groundbreaking Joint Venture with EnerTech, a KIA Entity, to Deploy $18B in U.S. Underground Utility Projects
EarthGrid, a Bay-area plasma tunnel-boring technology and infrastructure development company, announced today that it has signed a joint venture agreement with EnerTech, a Kuwait Investment Authority (KIA) entity, to deploy infrastructure projects in four phases across the United States, Europe and the Middle East. The first two phases consist of, in estimate, $18 billion in U.S. infrastructure improvement projects. Utilizing EarthGrid’s patented plasma-powered machines, this joint venture will develop a network of underground tunnels designed to upgrade the current power...
17Sep
RevBio Receives a $2.4 Million NIH Grant to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation and Enrolls First Five Patients
RevBio, Inc., announced that it has been awarded a $2.4 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Neurological Disease and Stroke (NINDS), part of the National Institutes of Health (NIH). This two-year grant (1R44NS135736-01A1) will allow the company to complete a 20-patient pilot clinical trial to examine the safety and efficacy of the company’s bone adhesive biomaterial called TETRANITE® which will be used to immediately fixate cranial flaps and enable bone fusion following...
17Sep
Xylyx Bio awarded $2.45M NIH SBIR grant from NIDDK to facilitate development of effective drugs for fibrotic liver disease
Xylyx Bio, Inc., a regenerative medicine company developing pioneering solutions for tissue and organ modeling and repair, announced today that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to advance commercial development of its InMatrico® disease modeling and drug testing platform to help scientists discover and test drug candidates for liver fibrosis. Fibrosis is a prevalent disease process...
13Sep
Stories that Inspire: Dr. Rahul Singh, Co-founder, EcoSoul Home
Discover how gifted entrepreneurs turned their dreams into reality! Join us for powerful mini-talks on chasing dreams, disrupting norms, and overcoming setbacks. Dr. Rahul Singh, Co-founder, EcoSoul Home. Watch now >>
13Sep
Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the official launch of the Myomo Academy, a comprehensive learning management system for professionals in Orthotics & Prosthetics (O&P) and Rehabilitation. The Myomo Academy is being launched during the 2024 AOPA (American Orthotic and Prosthetic Association) National Assembly, which is underway in Charlotte, NC until September 15, 2024. The Myomo Academy is designed to provide ongoing education, featuring...
13Sep
Wasabi Technologies Joins Forces with Grass Valley as Cloud Storage Provider of Choice to Enable Streamlined Media Archiving for Live Events
Wasabi Technologies, the hot cloud storage company, today announced that Grass Valley, a leading media technology provider for the media and entertainment industry, will offer Wasabi’s low-cost, high-performance cloud storage within AMPP. Grass Valley customers can now purchase and easily use Wasabi cloud storage within AMPP to enable efficient and flexible media production workflows for live event content creation, management, and distribution. Pairing these capabilities with Wasabi’s trusted cloud storage that does not charge for egress, AMPP users can freely...
13Sep